EBS   $9.35  2.30% Market Closed After Close 9.31 -0.43%

Emergent BioSolutions Inc
Total Cash 69.70M
totalCashPerShare 1.317
EBITDA -79.30M
Total Debt 876.80M
quickRatio 0.429
currentRatio 1.056
Total Revenue 1.10B
debtToEquity 226.974
Revenue/Share 21.135
ROA -0.06415
ROE -0.87442
grossProfits
freeCashflow 8.05M
operatingCashflow 77.00M
earningsGrowth
revenueGrowth -0.246
grossMargins 0.19815001
ebitdaMargins -0.07195
operatingMargins -0.62466
profitMargins -0.53257
enterpriseValue 1.29B
forwardPE 3.0735784
floatShares 51.88M
sharesOutstanding 52.91M
sharesShort 8.23M
sharesShortPriorMonth 3.84M
dateShortInterest
sharesPercentSharesOut 0.16%
heldPercentInsiders 0.02%
heldPercentInstitutions 0.58%
Short Ratio help_outline 3.12%
shortPercentOfFloat 0.19%
impliedSharesOutstanding
bookValue 7.302
Price To Book help_outline 1.26
earningsQuarterlyGrowth
netIncomeToCommon -587.00M
trailingEps -11.22%
forwardEps 2.99%
enterpriseToEbitda -16.31
lastDividendValue
lastDividendDate
currentQuarterEstimate 0.14 3Q 2024
institutionsCount 175
lastUpdated Oct. 16, 2024, 10:24 a.m.